These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9480114)

  • 1. [Resuscitation necessitated by a transfusion reaction after HLA mismatched platelets substitution].
    Kuntz BM; Schöttler B; Brüster HT
    Beitr Infusionsther Transfusionsmed; 1994; 32():307-9. PubMed ID: 9480114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
    Taaning E; Jacobsen N
    Transplant Proc; 1994 Jun; 26(3):1826. PubMed ID: 8030157
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test.
    Barba P; Pallarés P; Nogués N; Canals C; Gracia M; Vinyets I; Muñiz-Diaz E
    Transfus Med; 2010 Jun; 20(3):200-2. PubMed ID: 19919615
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
    Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
    Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Labile blood products from donors immunized against the HLA system. Apropos of a case of transfusional pulmonary edema].
    Fruchart MF; Belhocine R; Klaren J; Ben Hadj Amor H; Fretz C
    Transfus Clin Biol; 1998 Dec; 5(6):381-4. PubMed ID: 9894328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
    Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
    J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion of leukocytes and platelets in the treatment of acute leukemia].
    Baklaja R; Stajić M; Banicević B; Jancić M; Cvetković V; Maslovarić S; Susaković N; Andelić M; Stefanović S
    Bilt Hematol Transfuz; 1978; 6(3):31-8. PubMed ID: 295220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report.
    Sasaki M; Yagihashi A; Kobayashi D; Watanabe N; Fujikawa T; Chiba S; Sato S; Morishita K; Sekimoto T; Ikeda H
    Pediatr Hematol Oncol; 2001 Dec; 18(8):519-24. PubMed ID: 11764101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
    Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
    Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
    Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-HLA antibodies after rejection of HLA identical kidney transplants.
    Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
    Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukaemia cutis in a patient treated for breast cancer.
    Weinel S; Malone J; Jain D; Callen JP
    Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies.
    Masson E; Stern M; Chabod J; Thévenin C; Gonin F; Rebibou JM; Tiberghien P
    J Heart Lung Transplant; 2007 Jun; 26(6):642-5. PubMed ID: 17543791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.
    Yamashita T; Ikegame K; Kojima H; Tanaka H; Kaida K; Inoue T; Ogawa H
    Bone Marrow Transplant; 2017 May; 52(5):794-796. PubMed ID: 28165448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.